A direct test of a metabolic claim
Can taking NR improve insulin sensitivity? A randomized trial by Dollerup and colleagues addressed that question in 40 sedentary men aged 40–70 with obesity and insulin resistance. Participants received oral NR or placebo for 12 weeks. Researchers used a hyperinsulinemic-euglycemic clamp and other metabolic measurements, rather than relying only on a blood NAD result. [1]
The study found no improvement in insulin sensitivity or whole-body glucose metabolism. Resting energy expenditure, lipid breakdown and body composition also did not improve. Investigators observed no serious adverse events attributed to NR, and safety blood tests were normal during the trial. That is a bounded safety observation, not an assurance about indefinite use. [1]
Why the measurement matters
This is a useful paper to bring to a claim that an NAD precursor “optimizes metabolism.” That phrase can hide several separate promises. A change in glucose handling, a change in weight and a change in how energetic someone feels each require their own answer. Here, the researchers directly investigated a glucose-related claim, so their negative finding belongs in the discussion.
It would also be a mistake to turn the result into a verdict on every possible NR application. The participants had a particular metabolic profile, and the study had a defined duration. A careful reading neither erases the negative result nor expands it beyond the question that was tested.
Keep the study separate from a weight-loss offer
A seller may place this paper beside animal research or a mechanism diagram. Read each item independently. A rationale for running a human experiment is not the same thing as a favorable result from that experiment. Ask the seller to identify the actual human outcome supporting its specific claim.
If weight loss is the advertised benefit, look for a weight-management trial with a relevant comparison, meaningful follow-up and clearly reported outcomes. Do not substitute this study’s investigation of metabolic physiology for evidence about a commercial weight-loss program. Our ingredient guide also explains why NR findings do not automatically apply to NMN or injected NAD+.
How to use this evidence
Write down the claim in a complete sentence before evaluating a citation. “This oral NR product improves insulin sensitivity in people like me” is more testable than “supports healthy aging.” Then compare the population, product and endpoint with the paper.
For another view of this research program, read the muscle mitochondrial analysis. Related publications can examine different outcomes from the same trial; they should not be counted as independent replications. Clinical questions about insulin resistance belong with a qualified healthcare professional.